Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls.

Morganti, Stefania; Ivanova, Mariia; Ferraro, Emanuela; Ascione, Liliana; Vivanet, Grazia; Bonizzi, Giuseppina; Curigliano, Giuseppe; Fusco, Nicola; Criscitiello, Carmen.

Afiliação

Morganti S; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan 20144, Italy.
Ivanova M; Department of Oncology and Haemato-Oncology, University of Milano, Milan 20122, Italy.
Ferraro E; Breast Oncology Center, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA.
Ascione L; Biobank for Translational and Digital Medicine Unit, IEO, European Institute of Oncology IRCCS, Milan 20144, Italy.
Vivanet G; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan 20144, Italy.
Bonizzi G; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Curigliano G; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan 20144, Italy.
Fusco N; Department of Oncology and Haemato-Oncology, University of Milano, Milan 20122, Italy.
Criscitiello C; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan 20144, Italy.